Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Haas Jason Create: Alert

All | News | Filings
Date FiledTypeDescription
04/04/2023 4 Haas Jason (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 623 shares @ $2.58, valued at $1.6k
Exercised 2,000 restricted stock units @ $0
10/11/2022 4 Haas Jason (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 49,750 options to buy @ $6.73, valued at $334.8k
Granted 37,750 restricted stock units @ $0
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
02/17/2022 4 Haas Jason (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 125,000 options to buy @ $1.59, valued at $198.8k
Granted 80,000 restricted stock units @ $0
10/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy